Expression of surface antigens during the differentiation of human dendritic cells vs macrophages from blood monocytes in vitro (scientific article published on 01 June 1999)

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

Q28251443

The dendritic cell system and its role in immunogenicity

Q29619870

CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines

Q33838538

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells

Q34029001

Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication

Q36348033

Proliferating dendritic cell progenitors in human blood

Q36363279

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

Q36366124

Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity

Q36366130

CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha

Q36367113

In vivo detection of dendritic cell antigen presentation to CD4(+) T cells.

Q36377341

CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells

Q37698653

Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T-cell recognition of nominal antigen

Q37730529

Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy

Q38624477

Recent advances in the study of dendritic cells and follicular dendritic cells.

Q40606529

CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model.

Q41332088

Phenotypic and functional differences between human dendritic cells derived in vitro from hematopoietic progenitors and from monocytes/macrophages.

Q43611931

CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40.

Q45878144

Differentiation of human dendritic cells from monocytes in vitro.

Q51106538

Presentation of peptides by cultured monocytes or activated T cells allows specific priming of human cytotoxic T lymphocytes in vitro

Q56909321

Differentiation of Human Monocytes into CD14 Negative Accessory Cells: Do Dendritic Cells Derive from the Monocytic Lineage?

Q67699013

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability

Q71615065

Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts

Q73209043

P433

issue

P304

page(s)

187-204

P577

publication date

1999-06-01

P1433

published in

Immunobiology

Q15754985

P1476

title

Expression of surface antigens during the differentiation of human dendritic cells vs macrophages from blood monocytes in vitro

P478

volume

200

Reverse relations

cites work (P2860)

Q38552928	CD86 molecule is a specific marker for canine monocyte-derived dendritic cells.
Q40797136	Cell culture conditions affect LPS inducibility of the inflammatory mediators in J774A.1 murine macrophages
Q93020630	Class II MHC antigen processing in immune tolerance and inflammation
Q46249268	Composition and surface charge of DNA-loaded microparticles determine maturation and cytokine secretion in human dendritic cells
Q37746786	Dendritic cells and macrophages are productively infected by poliovirus
Q45735566	Effect of the deletion of US2 and US3 from herpes simplex virus type 2 on immune responses in the murine vagina following intravaginal infection
Q40243960	HBV genes induce cytotoxic T-lymphocyte response upon adeno-associated virus (AAV) vector delivery into dendritic cells
Q43438121	HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.
Q35936770	Human breast cancer cells educate macrophages toward the M2 activation status
Q36483341	Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial.
Q47992744	Identifying and structurally characterizing CD1b in Aotus nancymaae owl monkeys
Q53922274	In vitro induction of tumor-specific HLA class I-restricted CD8+ cytotoxic T lymphocytes from patients with locally advanced breast cancer by tumor antigen-pulsed autologous dendritic cells.
Q57218521	Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix
Q37352655	Induction of tumour-specific CD8(+) cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer
Q33804742	Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes
Q33910726	Lipoprotein-dependent and -independent immune responses to spirochetal infection
Q33599240	Regulation of cytokine expression in mice immunized with cryptococcal polysaccharide, a glucuronoxylomannan (GXM), associated with peritoneal antigen-presenting cells (APC): requirements for GXM, APC activation, and interleukin-12
Q40632606	Restoration of tumor-specific HLA class I restricted cytotoxicity in tumor infiltrating lymphocytes of advanced breast cancer patients by in vitro stimulation with tumor antigen-pulsed autologous dendritic cells.
Q35549065	The adhesive and immunomodulating properties of the multifunctional Staphylococcus aureus protein Eap
Q33780559	Virus-specific CD4+ and CD8+ cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polio

P356	DOI	10.1016/S0171-2985(99)80069-2
P8608	Fatcat ID	release_vqoslngnazhhjjvm646tmky7ly
P698	PubMed publication ID	10416127